In this second edition of Primer on Multiple Sclerosis, the latest updates on therapeutics will be provided, including new medications that have been FDA- approved since the first edition.
In this second edition of Primer on Multiple Sclerosis, the latest updates on therapeutics will be provided, including new medications that have been FDA- approved since the first edition.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Barbara S. Giesser, MD is Clinical Director at UCLA MS Clinical Service, David Geffen School of Medicine, Los Angles, CA.
Inhaltsangabe
* Part 1: Historical Background * Chapter 1: The History of Multiple Sclerosis: From the Age of Description to the Age of Therapy * T. Jock Murray * Part 2: Basic Science * Chapter 2: Genetics and Epidemiology in Multiple Sclerosis * Gabriele C. DeLuca, Richard L. Yates and A. Dessa Sadovnick * Chapter 3: Neurophysiology of Multiple Sclerosis * Jefferson C. Slimp * Chapter 4: Immunology of Multiple Sclerosis * Laura Piccio and Anne H. Cross * Chapter 5: Taking a Microscopic Look at Multiple Sclerosis * Yong Guo and Claudia F. Lucchinetti * Part 3: Diagnosis and Prognosis * Chapter 6: Diagnosis of Multiple Sclerosis * Loren A. Rolak * Chapter 7: Neuroimaging in Multiple Sclerosis * Megan Esch and Nancy L. Sicotte * Chapter 8: Cerebrospinal Fluid Profile Supporting a Clinical Definite Multiple Sclerosis Diagnosis * Mark Freedman and Mohammed Abdoli * Chapter 9: Evoked Potentials * Marc R. Nuwer * Chapter 10: Temporal and Clinical Course of Multiple Sclerosis * Erica Grazioli, Cornelia Mihai, and Bianca Weinstock-Guttman * Chapter 11: Outcome Measures in Multiple Sclerosis * Robert M. Herndon * Part 4: Clinical Manifestations * Chapter 12: Neuro-Ophthalmologic Manifestations of Multiple Sclerosis * Shin C. Beh, Elliot M. Frohman, and Teresa Frohman * Chapter 13: Cerebellar and Brainstem Dysfunction in Multiple Sclerosis * Angeli S. Mayadev and George H. Kraft * Chapter 14: Disorders of Mobility in Multiple Sclerosis * Scott Campea and Jodie K. Haselkorn * Chapter 15: Management of Urinary and Bowel Dysfunction in Patients with Multiple Sclerosis * Ja-Hong Kim and Judy M. Choi * Chapter 16: Assessment and Treatment of Sexual Dysfunction in Multiple Sclerosis * Frederick W. Foley * Chapter 17: Gender and Reproductive Issues in Multiple Sclerosis * Rhonda Voskuhl and Barbara S. Giesser * Chapter 18: Cognitive Impairment and Mood Disturbances * Nicholas G. LaRocca * Chapter 19: Multiple Sclerosis and Pain * Norman S. Namerow * Chapter 20: Fatigue in Multiple Sclerosis * Vikram Bhise, Leigh Charvet, and Lauren Krupp * Chapter 21: Sleep Disorders in Multiple Sclerosis * Tiffany J. Braley and Alon Y. Avidan * Chapter 22: Pediatric Multiple Sclerosis * J.M. Tillema, J. Graves, L.A. Benson, G.S. Aaen, A. Belman, J. Parrish, B. Weinstock-Guttman, L. Krupp, T. Chitnis, and E. Waubant, * Part 5: Therapeutics * Chapter 23: Neuromyelitis Optica Spectrum Disorders * Dean M. Wingerchuk * Chapter 24: Multiple Sclerosis Nursing * Kirstin Nygren and Gail Hartley * Chapter 25: Immunomodulatory Agents for Relapsing-Remitting Multiple Sclerosis * Jessica F. Robb and Lawrence M. Samkoff * Chapter 26: Immunosuppressive and Novel Therapies * Barbara S. Giesser * Chapter 27: Complementary and Alternative Medicine in Multiple Sclerosis * Allen C. Bowling * Part 6: Psychosocial Issues * Chapter 28: Living with Multiple Sclerosis: The Psychosocial Challenges for Patients and Their Families Rosalind C. Kalb * Chapter 29: Employment and Career Development Considerations * Steven W. Nissen and Phillip D. Rumrill, Jr. * Chapter 30: Legal Planning Issues * Laura D. Cooper, Esq. * Part 7: Research * Chapter 31: Issues in the Design and Interpretation of Multiple Sclerosis Clinical Trials * Stephen Krieger, Ilana Katz Sand, Svenja Oynhausen, and Aaron Miller * Chapter 32: Basic Science in Multiple Sclerosis: Progress and Promise * Wendy Gilmore and Leslie P. Weiner
* Part 1: Historical Background * Chapter 1: The History of Multiple Sclerosis: From the Age of Description to the Age of Therapy * T. Jock Murray * Part 2: Basic Science * Chapter 2: Genetics and Epidemiology in Multiple Sclerosis * Gabriele C. DeLuca, Richard L. Yates and A. Dessa Sadovnick * Chapter 3: Neurophysiology of Multiple Sclerosis * Jefferson C. Slimp * Chapter 4: Immunology of Multiple Sclerosis * Laura Piccio and Anne H. Cross * Chapter 5: Taking a Microscopic Look at Multiple Sclerosis * Yong Guo and Claudia F. Lucchinetti * Part 3: Diagnosis and Prognosis * Chapter 6: Diagnosis of Multiple Sclerosis * Loren A. Rolak * Chapter 7: Neuroimaging in Multiple Sclerosis * Megan Esch and Nancy L. Sicotte * Chapter 8: Cerebrospinal Fluid Profile Supporting a Clinical Definite Multiple Sclerosis Diagnosis * Mark Freedman and Mohammed Abdoli * Chapter 9: Evoked Potentials * Marc R. Nuwer * Chapter 10: Temporal and Clinical Course of Multiple Sclerosis * Erica Grazioli, Cornelia Mihai, and Bianca Weinstock-Guttman * Chapter 11: Outcome Measures in Multiple Sclerosis * Robert M. Herndon * Part 4: Clinical Manifestations * Chapter 12: Neuro-Ophthalmologic Manifestations of Multiple Sclerosis * Shin C. Beh, Elliot M. Frohman, and Teresa Frohman * Chapter 13: Cerebellar and Brainstem Dysfunction in Multiple Sclerosis * Angeli S. Mayadev and George H. Kraft * Chapter 14: Disorders of Mobility in Multiple Sclerosis * Scott Campea and Jodie K. Haselkorn * Chapter 15: Management of Urinary and Bowel Dysfunction in Patients with Multiple Sclerosis * Ja-Hong Kim and Judy M. Choi * Chapter 16: Assessment and Treatment of Sexual Dysfunction in Multiple Sclerosis * Frederick W. Foley * Chapter 17: Gender and Reproductive Issues in Multiple Sclerosis * Rhonda Voskuhl and Barbara S. Giesser * Chapter 18: Cognitive Impairment and Mood Disturbances * Nicholas G. LaRocca * Chapter 19: Multiple Sclerosis and Pain * Norman S. Namerow * Chapter 20: Fatigue in Multiple Sclerosis * Vikram Bhise, Leigh Charvet, and Lauren Krupp * Chapter 21: Sleep Disorders in Multiple Sclerosis * Tiffany J. Braley and Alon Y. Avidan * Chapter 22: Pediatric Multiple Sclerosis * J.M. Tillema, J. Graves, L.A. Benson, G.S. Aaen, A. Belman, J. Parrish, B. Weinstock-Guttman, L. Krupp, T. Chitnis, and E. Waubant, * Part 5: Therapeutics * Chapter 23: Neuromyelitis Optica Spectrum Disorders * Dean M. Wingerchuk * Chapter 24: Multiple Sclerosis Nursing * Kirstin Nygren and Gail Hartley * Chapter 25: Immunomodulatory Agents for Relapsing-Remitting Multiple Sclerosis * Jessica F. Robb and Lawrence M. Samkoff * Chapter 26: Immunosuppressive and Novel Therapies * Barbara S. Giesser * Chapter 27: Complementary and Alternative Medicine in Multiple Sclerosis * Allen C. Bowling * Part 6: Psychosocial Issues * Chapter 28: Living with Multiple Sclerosis: The Psychosocial Challenges for Patients and Their Families Rosalind C. Kalb * Chapter 29: Employment and Career Development Considerations * Steven W. Nissen and Phillip D. Rumrill, Jr. * Chapter 30: Legal Planning Issues * Laura D. Cooper, Esq. * Part 7: Research * Chapter 31: Issues in the Design and Interpretation of Multiple Sclerosis Clinical Trials * Stephen Krieger, Ilana Katz Sand, Svenja Oynhausen, and Aaron Miller * Chapter 32: Basic Science in Multiple Sclerosis: Progress and Promise * Wendy Gilmore and Leslie P. Weiner
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826
